One Wealth Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,427
Closed -$112K 358
2022
Q4
$112K Buy
+1,427
New +$115K 0.03% 273
2019
Q3
Sell
-4,236
Closed -$510K 121
2019
Q2
$510K Sell
4,236
-258
-6% -$25.4K 0.42% 34
2019
Q1
$393K Buy
4,494
+221
+5% +$20.1K 0.32% 48
2018
Q4
$428K Buy
4,273
+6
+0.1% +$630 0.43% 32
2018
Q3
$489K Buy
+4,267
New +$442K 0.37% 37

Other funds holding HAE

One Wealth Advisors's HAE Position: Q1 2023 in Review

One Wealth Advisors sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 1,427 shares — an estimated $112K sold.

One Wealth Advisors first reported a position in HAE in Q3 2018 and held it in 5 quarters. The position peaked at $510K in Q2 2019. 300 funds tracked by Wall St. Rank hold HAE as of Q1 2023.

  • One Wealth Advisors reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
  • One Wealth Advisors sold 1,427 Haemonetics shares in Q1 2023, an estimated $112K.
  • One Wealth Advisors first reported a position in Haemonetics in Q3 2018 and held it in 5 quarters.
  • One Wealth Advisors's Haemonetics position peaked at $510K in Q2 2019.
  • 300 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.

Based on One Wealth Advisors's 13F filing for Q1 2023, filed 15 May 2023.